# Ten Years in Remission: The Long-Term Journey of a Breast Cancer Survivor

## TL;DR

A breast cancer patient achieved 10 years of remission through personalized treatment, but later developed a second cancer and treatment-related complications.

## Contribution

Demonstrates the potential for long-term remission in metastatic breast cancer with tailored, multidisciplinary care.

## Key findings

- The patient achieved complete remission of metastatic breast cancer in 2016 and remained disease-free until 2025.
- She later developed a second primary gastric adenocarcinoma in 2024 and experienced treatment-related hepatic toxicity.
- The case highlights the importance of long-term monitoring for secondary cancers and late treatment effects.

## Abstract

Metastatic breast cancer (MBC) remains a challenging clinical entity, with long-term remission being rare. We report the case of a 51-year-old woman diagnosed in 2009 with HER2-positive, hormone receptor-positive invasive carcinoma of the right breast with extensive hepatic metastases. Following multimodal treatment, including surgery, multiple lines of chemotherapy, targeted therapy, and hormonal therapy, she achieved complete remission of metastatic disease in 2016 and remained disease-free until her death in 2025. Her clinical course was later complicated by the development of a second primary gastric adenocarcinoma in 2024, as well as treatment-related hepatic toxicity. This case illustrates that, in selected patients, prolonged remission can be achieved through a multidisciplinary, personalized treatment strategy and personalized approach. At the same time, it underscores the critical importance of long-term surveillance for secondary malignancies and late treatment-related adverse effects.